Hawthorn Pharmaceuticals, Inc., established in 1998, is a specialty pharmaceutical company focused on the sales, marketing and development of branded prescription products primarily in specialty-driven markets. Hawthorn has an existing strong presence and demonstrated commitment to meeting the needs of patients and physicians in these target markets.

Hawthorn Pharmaceuticals endeavors to be a distinguished leader and partner of choice in bringing innovative, niche products and technologies to market.

Sales and Marketing
As Hawthorn has grown, so have its marketing and sales capabilities.  Today, Hawthorn’s professional sales force consists of approximately 120 individuals throughout the United States.  The sales force is led by seasoned, industry veterans and includes an unrivaled training and development program.  The company has established relationships will all major purchases of pharmaceuticals in the United States, including all major chains and wholesalers.  These relationships have been built based upon the Hawthorn’s focus on quality, integrity and service to its customers.

Organic Growth
Hawthorn has a strong portfolio of core marketed products.  These products provide revenue and cash flow that enable Hawthorn to invest in the future of the company through the continuing expansion of its sales force, development of products in the company’s pipeline and business development collaborations.

Product Development
The company has an aggressive product development pipeline including new drug applications (“NDAs”), 505(b)(2) applications, and abbreviated new drug applications (“ANDAs”) with 13 products in various stages of development. Hawthorn currently has 3 submissions with the Food and Drug Administration (“FDA”) with up to 9 submissions expected to be filed in 2008.  Hawthorn’s product development initiatives are led by its in-house team of drug development experts.